Interleukin-22: the hub bridging gut homeostasis and metabolism
Trends in Immunology · 2026
DOI: 10.1016/j.it.2025.10.009 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Immunology, 2026. Verfasst von Shupei Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Liver Cancer Institute, Zhongshan Hospit…. Hauptthemen laut MEDLINE: Interleukins, Inflammatory Bowel Diseases, Intestinal Mucosa. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 114 Literaturangaben. Gefördert von: National Science and Technology Council, National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
IL-22, produced by various cell types including T helper (Th) 17 cells and group 3 innate lymphoid cells (ILC3s), plays a pivotal role in gut homeostasis by acting on non-hematopoietic cells. It promotes epithelial barrier integrity, tissue repair, and antimicrobial defense. Beyond its established function in mucosal immunity, emerging evidence reveals IL-22's involvement in regulating intestinal metabolism and protecting against systemic metabolic dysregulation. This review highlights recent advances in preclinical mouse models and human clinical data in IL-22 biology, focusing on its dual role in immune defense and metabolic control. Given the strong link between inflammatory bowel disease (IBD) and metabolic disorders, we further discuss IL-22's therapeutic potential in mitigating both intestinal inflammation and related metabolic complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200438, China.
- The Human Phenome Institute, Center for Integrative Spatial-Omics Research, Zhangjiang-Fudan International Innovation Center, Fudan University, Shanghai 200438, China. Electronic address: jiaxiwang@fudan.edu.cn.
- Institute of Molecular Biology, Academia Sinica, Taipei 11529, Taiwan. Electronic address: Wangweile@as.edu.tw.
- Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200438, China. Electronic address: Liha…
Förderung
- National Science and Technology Council
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Wang, S., Gong, J., Wang, J., Wang, W. L., & Huang, L. H. (2026). Interleukin-22: the hub bridging gut homeostasis and metabolism. Trends in Immunology. https://doi.org/10.1016/j.it.2025.10.009
Vancouver
Wang S, Gong J, Wang J, Wang WL, Huang LH. Interleukin-22: the hub bridging gut homeostasis and metabolism. Trends in Immunology. 2026. doi:10.1016/j.it.2025.10.009
BibTeX
@article{Wang2026,
author = {Wang, Shupei and Gong, Jingyi and Wang, Jiaxi and Wang, Wei-Le and Huang, Li-Hao},
title = {Interleukin-22: the hub bridging gut homeostasis and metabolism},
journal = {Trends in Immunology},
year = {2026},
doi = {10.1016/j.it.2025.10.009}
}
EUVIMED